GSK Paxil CR Ad Medicalizes “Ordinary” Anxiety, FDA Says
GlaxoSmithKline Paxil CR TV ads suggest the antidepressant is appropriate for treating anxiety that does not require medication, FDA's ad division says
You may also be interested in...
GlaxoSmithKline's off-the-shelf response to requests for information about off-label use of Paxil in pediatric patients notes that there are studies demonstrating efficacy of paroxetine in obsessive/compulsive disorder and social anxiety disorder
Fallout from GlaxoSmithKline's handling of Paxil pediatric studies may lead to increased pressure by Congress or FDA for greater disclosure, Schering-Plough Senior VP-Global Compliance & Business Practices Brenton Saunders said
FDA is challenging Wyeth Effexor/Effexor XR promotions that suggest the antidepressant is more effective than SSRIs